These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 12962007)
61. [Immunotherapy--nursing requirements--presentation of care in immunotherapy with monoclonal antibodies as a part of the treatment of metastasized neuroblastoma IV]. Lehner C Kinderkrankenschwester; 1998 Nov; 17(11):476-80. PubMed ID: 9887744 [No Abstract] [Full Text] [Related]
62. Current Development of Monoclonal Antibodies in Cancer Therapy. Parakh S; King D; Gan HK; Scott AM Recent Results Cancer Res; 2020; 214():1-70. PubMed ID: 31473848 [TBL] [Abstract][Full Text] [Related]
63. Toxicity Management: Development of a Novel and Immune-Mediated Adverse Events Algorithm . Mistry H; Forbes SG; Fowler N Clin J Oncol Nurs; 2017 Apr; 21(2 Suppl):53-59. PubMed ID: 28315558 [TBL] [Abstract][Full Text] [Related]
65. The clinical uses of monoclonal antibodies in cancer research. Moldawer NP; Murray JL Cancer Nurs; 1985 Aug; 8(4):207-13. PubMed ID: 3850786 [No Abstract] [Full Text] [Related]
66. [Monoclonal antibody for cancer treatment]. Achiwa H; Sato S; Ueda R Gan To Kagaku Ryoho; 2002 Apr; 29(4):495-501. PubMed ID: 11977531 [TBL] [Abstract][Full Text] [Related]
67. Advocating for quality cancer care: making evidence-based practice a reality. Mooney KH Oncol Nurs Forum; 2001 Mar; 28(2 Suppl):17-21. PubMed ID: 11291208 [TBL] [Abstract][Full Text] [Related]
68. Immunohistochemically detecting target antigens in patient biopsies for tailoring monoclonal antibody based cancer therapy. Smith NL; Finley JL; Wennerberg AE; Semer DA; Kearse KP Hum Antibodies; 1999; 9(1):61-5. PubMed ID: 10331187 [TBL] [Abstract][Full Text] [Related]
72. A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism. Nelson B Cancer Cytopathol; 2014 Jan; 122(1):1-2. PubMed ID: 24424750 [No Abstract] [Full Text] [Related]
73. Anticancer antibodies. Ross JS; Gray K; Gray GS; Worland PJ; Rolfe M Am J Clin Pathol; 2003 Apr; 119(4):472-85. PubMed ID: 12710120 [TBL] [Abstract][Full Text] [Related]
74. New developments in immunotherapy for pediatric solid tumors. Schultz LM; Majzner R; Davis KL; Mackall C Curr Opin Pediatr; 2018 Feb; 30(1):30-39. PubMed ID: 29189429 [TBL] [Abstract][Full Text] [Related]
75. Immunotherapy Summit: Proceedings and Identified Priorities for Safe Administration and Care. Galioto M; Mucenski J Clin J Oncol Nurs; 2019 Jun; 23(3):E60-E65. PubMed ID: 31099794 [TBL] [Abstract][Full Text] [Related]
76. Cancer and the Immune System: The History and Background of Immunotherapy. Abbott M; Ustoyev Y Semin Oncol Nurs; 2019 Oct; 35(5):150923. PubMed ID: 31526550 [TBL] [Abstract][Full Text] [Related]
77. Aspects of immunobiology and immunotherapy and uses of monoclonal antibodies and biologic immune modifiers in human gliomas. Lee Y; Bigner DD Neurol Clin; 1985 Nov; 3(4):901-17. PubMed ID: 2417097 [TBL] [Abstract][Full Text] [Related]